slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 71,101-71,130
Pages 3,679
Rows per page 30
Component
71,101-71,130 of 110,355
52
MindMed | Investor Day Presentation Deck | 61 slidesMindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
53
The chart displays STAI-G scores over 24 weeks, highlighting a statistically significant divergence between the LSD and placebo groups.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
54
The chart shows a clear dose-response relationship with high dose performing significantly better than low dose.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
55
The slide uses a timeline-based study design diagram to illustrate the randomization and follow-up periods.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
56
MindMed | Investor Day Presentation Deck | 61 slidesMindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
59
The slide uses a process-oriented layout to define the commercialization strategy.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
06
Uses a pictogram (4/5 dark blue) to visually represent the '1 in 5' statistic.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a matrix structure to categorize drug development strategy by generation (Classic, 2nd Gen/Optimized, 3rd Gen/NCEs).MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a flywheel diagram to represent the R&D strategy and a bar chart to demonstrate the impact of IP strategies on market protection duration.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
Uses a brain diagram to map specific therapeutic areas to clinical evidence points.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Uses a brain scan visualization to illustrate the impact of a serotonin agonist.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · Market Size1 hit
13
The slide uses a table to establish historical credibility for the company's therapeutic approach.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
14
Data source: Holze, Gasser et al. 2022. Biological Psychiatry.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
15
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
17
The slide uses a timeline diagram to illustrate the study flow from randomization to follow-up.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
18
The slide uses a process-oriented layout to describe the commercialization strategy.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
21
The chart demonstrates the therapeutic index advantage of the R-enantiomer.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
22
The chart shows a comparison between Placebo and MDMA at 1 month and 6 months, indicating sustained improvement.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
25
The slide uses two distinct chart types (bar and line) to show efficacy across different translational markers.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
26
The slide uses a clear, bulleted list to summarize clinical trial outcomes.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
31
The slide uses a timeline-based framework to map specific digital solutions to different stages of drug development.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
06
The slide uses a combination of a line chart for share price and a bar chart for cumulative cash burn to illustrate value destruction.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · AgitateLoop · Cost Of Inaction1 hit
07
The slide uses a contrast-based layout to highlight performance failures.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · AgitateLoop · Cost Of Inaction1 hit
08
Uses a 'villain_critique' approach to frame the target company as a value-destroying entity.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Agitate1 hit
09
The slide uses a combination of a stacked bar chart for analyst ratings and a line chart for share price performance to illustrate the 'villain's' (3D Systems) poor track record.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Agitate1 hit
10
Uses a combination of a donut chart for ownership and bar/line charts for financial performance to discredit the target company.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Agitate1 hit
11
Uses a 'Claim vs Reality' framework to discredit competitors' M&A strategies.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Solution1 hit
06
Includes IFRS vs non-IFRS reconciliation notes.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Future VisionLoop · Zoom In1 hit
08
The chart highlights Nano Dimension's superior performance (43%) compared to negative or low growth among peers.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Future Vision1 hit
09
The slide uses logos of acquired companies to represent the growth of the parent entity.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Future VisionLoop · Before After1 hit